Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

5.63
-0.3500-5.85%
Post-market: 5.800.1700+3.02%19:30 EDT
Volume:43.51K
Turnover:249.75K
Market Cap:3.08M
PE:-0.05
High:6.00
Open:5.89
Low:5.61
Close:5.98
52wk High:179.19
52wk Low:4.68
Shares:547.78K
Float Shares:547.42K
Volume Ratio:1.57
T/O Rate:7.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4151
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.62
PE(LYR):-0.02

Loading ...

Artelo Biosciences Expands Art27.13 Development as a Potential Companion Therapy to Glp-1 Treatments

THOMSON REUTERS
·
Mar 26

Artelo Biosciences expands ART27.13 into glaucoma via fully funded investigator-sponsored clinical study; glaucoma market totals $16.3 billion

Reuters
·
Mar 25

Artelo Biosciences files to sell 4.27M shares of common stock for holders

TIPRANKS
·
Mar 25

Artelo Biosciences Inc - May Receive up to $50 Mln in Gross Proceeds From Sales to Square Gate - SEC Filing

THOMSON REUTERS
·
Mar 25

Artelo reports 6.38% mean weight gain in interim CAReS trial results for ART27.13

Reuters
·
Mar 24

Artelo Biosciences files to sell 1.64M shares of common stock

TIPRANKS
·
Mar 21

Artelo Biosciences Secures Bridge Financing Through Note Issuance

TIPRANKS
·
Mar 19

Artelo Biosciences issues USD 350,300 in 12% unregistered bridge notes in private placement

Reuters
·
Mar 19

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

Top Midday Gainers

MT Newswires Live
·
Mar 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM

Reuters
·
Mar 18

BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist

Reuters
·
Mar 18

Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

GlobeNewswire
·
Mar 18

BRIEF-Artelo Announces Third-Party Fully Funded Clinical Study Agreement To Evaluate Art27.13 In Glaucoma Patients

Reuters
·
Mar 18

Artelo Biosciences Shares Jump 30% Premarket After Co Plans UK Study of Glaucoma Drug

THOMSON REUTERS
·
Mar 18

BUZZ-Artelo Biosciences jumps as it plans UK study of glaucoma drug

Reuters
·
Mar 18

Artelo announces third-party fully funded clinical study agreement for ART27.13

TIPRANKS
·
Mar 18

Artelo Biosciences signs investigator-initiated clinical study to test ART27.13 in glaucoma patients

Reuters
·
Mar 18

Artelo Biosciences Inc - to Supply Art27.13 Capsules as Investigational Medicinal Product

THOMSON REUTERS
·
Mar 18

Artelo Biosciences Inc - First Patient Enrollment Anticipated in Q2 2026

THOMSON REUTERS
·
Mar 18